Affichage 11 à 12 des 12 essais cliniques
1 | 2 |
1 |
2 |
1 | 2 |
ESSAIS CLINIQUES No essai ClinicalTrials.gov ID |
Phase | Coordonnateur(rice) | |
---|---|---|---|
(EN) A Randomized, Controlled Phase 3 Study of Pacritinib Versus Physician's Choice in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis With Severe Thrombocytopenia (Platelet Count <50,000/?L)
PACIFICA NCT03165734 ![]() |
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL![]() |
Sarah Barnier 514-340-8222 poste 26394 |
|
(EN) A Phase 1, Open-Label, Multicenter Study of INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
INCA 33989-101 NCT05936359 ![]() |
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL![]() |
Julie Trinh Lu 514-252-3400 poste 3336 |